Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Programmed Cell Death
100%
Hematologic Malignancy
100%
Oxidative Stress
100%
Motexafin
100%
Gadolinium Texaphyrin
100%
Porphyrin
33%
Non-Hodgkin Lymphoma
33%
B-Cell Chronic Lymphocytic Leukemia
33%
Clinical Trial
33%
Cancer Cell
16%
In Vitro
16%
Glutathione
16%
Tumor Cell
16%
Tumor Model
16%
Reactive Oxygen Species
16%
Gene Expression Profiling
16%
Chemotherapy Agent
16%
Cell Survival
16%
Thiol
16%
Rituximab
16%
B Cell
16%
Myeloma Cell Line
16%
Lymphocytic Lymphoma
16%
Hematopoietic System Malignancy
16%
Recombinant Gamma Interferon
16%
Cancer
16%
Ionizing Radiation
16%
Redox Stress
16%
Heat Shock Protein
16%
Metabolite
16%
Metallothionein
16%
Chemotherapy
16%
Heme Oxygenase
16%
Side Effect
16%
Nicotinamide Adenine Dinucleotide Phosphate
16%
Ascorbic Acid
16%
Ibritumomab Tiuxetan
16%
Immunology and Microbiology
Oxidative Stress
100%
Programmed Cell Death
100%
B Cell
33%
Tumor Cell
33%
Heat Shock
33%
Cancer Cell
33%
Cell Survival
33%
Rituximab
33%
Ibritumomab Tiuxetan
33%
Redox Stress
33%
Recombinant Gamma Interferon
33%
Myeloma Cell Line
33%
Metabolite
33%
Gene Expression Assay
33%
Glutathione
33%
Metallothionein
33%
In Vitro
33%
Dioxygen
33%
Ascorbic Acid
33%
Heme Oxygenase
33%
Vitamin C
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Gadolinium Texaphyrin
100%
Motexafin
100%
Clinical Trial
33%
Nonhodgkin Lymphoma
33%
Chronic Lymphatic Leukemia
33%
Porphyrin
33%
Chemotherapy Agent
16%
Malignant Neoplasm
16%
Reactive Oxygen Metabolite
16%
Remission
16%
Ionizing Radiation
16%
Tumor Model
16%
Glutathione
16%
Chemotherapy Regimens
16%
Heat Shock Protein
16%
Myeloma
16%
Rituximab
16%
Recombinant Gamma Interferon
16%
Lymphocytic Lymphoma
16%
Hematopoietic System Malignancy
16%
Heme Oxygenase
16%
Neoplasm
16%
Metallothionein
16%
Side Effect
16%
Nicotinamide Adenine Dinucleotide Phosphate
16%
Thiol
16%
Ascorbic Acid
16%
Ibritumomab Tiuxetan
16%